Dsc Advisors, L.P. Pfizer Inc Transaction History

Dsc Advisors, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $135,305 - $165,174	-3,092 Reduced 31.54%	6,712 $294,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $13,819 - $16,385	-297 Reduced 2.94%	9,804 $514,000
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $248,742 - $308,223	5,437 Added 116.57%	10,101 $523,000
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $6,115 - $9,065	-148 Reduced 3.08%	4,664 $275,000
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $188,871 - $242,621	4,812 New	4,812 $207,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $144,367 - $206,269	-5,341 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $175,825 - $199,539	5,341 New	5,341 $209,000
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $187,837 - $206,370	-5,009 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $192,696 - $219,694	5,009 New	5,009 $219,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Dsc Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Dsc Advisors, L.P. with notifications on news.